المؤلفون: Michels S; Klinik für Augenheilkunde und Optometrie, Medizinische Universität Wien, Währinger Gürtel 18-20, Allgemeines Krankenhaus 8i, 1090 Wien/Vienna, Austria. stephan.michels@meduniwien.ac.at, Schmidt-Erfurth U, Rosenfeld PJ

المصدر: Expert opinion on investigational drugs [Expert Opin Investig Drugs] 2006 Jul; Vol. 15 (7), pp. 779-93.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Taylor & Francis Country of Publication: England NLM ID: 9434197 Publication Model: Print Cited Medium: Internet ISSN: 1744-7658 (Electronic) Linking ISSN: 13543784 NLM ISO Abbreviation: Expert Opin Investig Drugs Subsets: MEDLINE

مواضيع طبية MeSH: Angiogenesis Inhibitors/*therapeutic use , Drugs, Investigational/*therapeutic use , Macular Degeneration/*drug therapy , Neovascularization, Pathologic/*drug therapy , Vascular Endothelial Growth Factor A/*antagonists & inhibitors, Aging ; Angiogenesis Inhibitors/pharmacology ; Animals ; Antibodies, Monoclonal/administration & dosage ; Antibodies, Monoclonal/economics ; Antibodies, Monoclonal/pharmacology ; Antibodies, Monoclonal/therapeutic use ; Antibodies, Monoclonal, Humanized ; Aptamers, Nucleotide/therapeutic use ; Bevacizumab ; Capillary Permeability/drug effects ; Cholestanols/therapeutic use ; Clinical Trials, Phase I as Topic ; Clinical Trials, Phase II as Topic ; Double-Blind Method ; Drug Design ; Drugs, Investigational/pharmacology ; Eye Proteins/physiology ; Humans ; Injections ; Lactates/therapeutic use ; Macular Degeneration/physiopathology ; Models, Animal ; Multicenter Studies as Topic ; Nerve Growth Factors/physiology ; Pigment Epithelium of Eye/metabolism ; Pigment Epithelium of Eye/pathology ; Protein Isoforms/antagonists & inhibitors ; Protein Isoforms/physiology ; RNA Interference ; RNA, Small Interfering/pharmacology ; RNA, Small Interfering/therapeutic use ; Randomized Controlled Trials as Topic ; Serpins/physiology ; Stilbenes/therapeutic use ; Treatment Outcome ; Vascular Endothelial Growth Factor A/pharmacology ; Vascular Endothelial Growth Factor A/physiology ; Vascular Endothelial Growth Factor Receptor-2/drug effects ; Vascular Endothelial Growth Factor Receptor-2/physiology ; Vitreous Body